Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Carcinoma, Medullary 9Lung Neoplasms 8Thyroid Neoplasms 7Neoplasms 5Neoplasm Metastasis 5Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Ovarian Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Stomach Neoplasms 2Pleural Effusion 2Kidney Neoplasms 2Gliosarcoma 2Glioblastoma 2Familial medullary thyroid carcinoma 2Fallopian Tube Neoplasms 2Urinary Bladder Neoplasms 1Thyroid cancer, medullary 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Small Cell Lung Carcinoma 1Recurrence 1Rectal Neoplasms 1Precancerous Conditions 1Peritoneal Neoplasms 1Oligodendroglioma 1Multiple Endocrine Neoplasia Type 2b 1Multiple Endocrine Neoplasia Type 2a 1

Interventions

Temozolomide 14Bevacizumab 11Erlotinib Hydrochloride 5Radiotherapy 4Carboplatin 4Magnetic Resonance Spectroscopy 3Irinotecan 3Immunoglobulin G 3Disulfides 3temsirolimus 2poly ICLC 2palbociclib 2etoposide phosphate 2antineoplaston AS 2-1 2antineoplaston A10 2Vincristine 2Sunitinib 2Sirolimus 2Everolimus 2Dasatinib 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2veliparib 1varlilumab 1vandetanib 1trebananib 1trametinib 1terameprocol 1tandutinib 1selinexor 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Oligodendroglioma × vandetanib × Clear all
NCT00995007 2016-03-29

A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
112 enrolled 12 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡